Discover 2,423 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,423
Circulating Tumor DNA
for
ER+ Breast Cancer
Location: Washington D.C. DC, Baltimore MD, The Bronx NY,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT06923527
Phase 2, Recruiting
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Teligene US
Sex: All
Age: 18+
Code: NCT05168566
Phase 2, Recruiting
Exercise Intolerance in Heart Failure
for
Heart Failure With Normal Ejection Fraction
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 21+
Code: NCT03775577
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Washington D.C. DC, Arlington VA, Fairfax VA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase 3, Recruiting
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
for
Solid Tumors, GI Cancer
Location: Washington DC, Baltimore MD, Durham NC, Boston MA,
Sponsor: Curegenix Inc.
Sex: All
Age: 18+
Code: NCT02675946
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
for
Ewing Sarcoma
Location: Baltimore MD, Philadelphia PA, Pittsburgh PA,
Sponsor: Amgen
Sex: All
Age: 2+
Code: NCT07297979
Phase 1, Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Washington D.C. DC, Falls Church VA, Baltimore MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase 2, Recruiting
PET Imaging in the Baltimore Longitudinal Study of Aging (BLSA)
for
Aging
Location: Baltimore MD
Sponsor: National Institute on Aging (NIA)
Sex: All
Age: 55 - 70+
Code: NCT07099053
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
for
Congenital Adrenal Hyperplasia,
Location: Baltimore MD, Charlottesville VA, Philadelphia PA,
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07144163
Phase 3, Recruiting
E-Mindfulness Approaches for Living After Breast Cancer
for
Breast Cancer, Depression
Location: Washington D.C. DC, McLean VA, Fairfax VA,
Sponsor: NRG Oncology
Sex: All
Age: 18 - 50
Code: NCT06748222
Phase 3, Recruiting
MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)
for
Femoral Neck Fractures
Location: Fairfax VA, Largo MD, Baltimore MD, Allentown PA,
Sponsor: University of Southern California
Sex: All
Age: 60+
Code: NCT07244211
Recruiting
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: Washington D.C. DC, Baltimore MD, Richmond VA,